Ace Report Cover
Nadroparin or fondaparinux for thromboprophylaxis after ankle/foot fracture managed conservatively
Reprints
Cite This
Reprints
Cite This
AceReport Image
Trauma
Nadroparin or fondaparinux for thromboprophylaxis after ankle/foot fracture managed conservatively
Verified
This report has been verified by one or more authors of the original publication.
Injury. 2017 Apr;48(4):936-940

467 patients managed with a below-knee plaster cast for a foot or ankle fracture were randomized to either subcutaneous nadroparin 2850IE daily, subcutaneous fondaparinux 2.5mg daily, or no thromboprophylaxis intervention (control). Patients were screened during follow-up for cases of deep vein thrombosis and pulmonary embolism. Results demonstrated significantly lower rates of deep vein thrombosis in both the nadroparin and fondaparinux groups compared to the control group. All but two cases of DVT in the control group were asymptomatic; symptomatic patients had pulmonary embolism confirmed by CT angiography.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Nadroparin or fondaparinux for thromboprophylaxis after ankle/foot fracture managed conservatively. ACE Report. 2017;7(12):7. Available from: https://myorthoevidence.com/AceReport/Report/nadroparin-or-fondaparinux-for-thromboprophylaxis-after-ankle-foot-fracture-managed-conservatively

Copy Citation
Share this Ace Report